Novel application of anti‐human Fc nanobody for screening high‐producing CHO cells for monoclonal antibody
Abstract Animal‐derived anti‐IgG secondary antibodies are currently employed to stain and screen of human monoclonal antibody(mAb)‐producing cells, but using animal‐derived antibodies may raise the concerns of high cost, complicated operations and biological safety issues in biopharmaceutical manufa...
Main Authors: | Di Zhu, Zheng Wang, Yunxia Xu, Jing Lin, Mei Qiu, Jianghai Liu, Xinlei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2022-10-01
|
Series: | Engineering in Life Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/elsc.202200028 |
Similar Items
-
Nanobody and Its Therapeutic Applications
by: Maryam Darvish
Published: (2018-04-01) -
Characterization of rabbit polyclonal antibody against camel recombinant nanobodies
by: Khalaf Houssam-Eddin, et al.
Published: (2022-06-01) -
Osmolality Effects on CHO Cell Growth, Cell Volume, Antibody Productivity and Glycosylation
by: Sakhr Alhuthali, et al.
Published: (2021-03-01) -
Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies
by: Kexue Liang, et al.
Published: (2023-01-01) -
Reduced Culture Temperature Differentially Affects Expression and Biophysical Properties of Monoclonal Antibody Variants
by: Megan Mason, et al.
Published: (2014-08-01)